Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion type Assertion NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_head.
- NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion description "[Although expression of OLIG2 is normally restricted to neural tissues, overexpression of OLIG2 has been shown in patients with precursor T-cell lymphoblastic lymphoma/leukemia (pre-T LBL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_provenance.
- NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion evidence source_evidence_literature NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_provenance.
- NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion SIO_000772 16103065 NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_provenance.
- NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion wasDerivedFrom befree-20150227 NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_provenance.
- NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_assertion wasGeneratedBy ECO_0000203 NP838621.RAzFvrLw19xGTGJH0ZzBoF9-oAdpNgkFib3-uLcBMRzdg130_provenance.